← All Vaxcyte, INC filings

Vaxcyte, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
PCVX
Vaxcyte, INC
DEF: Vaxcyte Sets 2026 Annual Meeting Date, Proposes Director Nominees
Vaxcyte, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 15, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NASDAQ
PCVX
Vaxcyte, INC
DEFA14A: Vaxcyte, Inc. Sets Date for 2025 Annual Meeting, Outlines Key Proposals for Stockholder Vote
Vaxcyte, Inc. announces its 2025 Annual Meeting of Stockholders to be held on June 12, 2025, outlining proposals for director elections, auditor ratification, executive compensation approval, and certificate of incorporation amendment.
NASDAQ
PCVX
Vaxcyte, INC
DEF: Vaxcyte Seeks Stockholder Approval for Officer Exculpation, Announces Annual Meeting
Vaxcyte, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, and an amendment for officer exculpation.
NASDAQ
PCVX
Vaxcyte, INC
DEFA14A: Vaxcyte, Inc. Sets Date for 2024 Annual Meeting, Outlines Proposals for Stockholder Vote
Vaxcyte, Inc. announces its 2024 Annual Meeting of Stockholders to be held on June 6, 2024, outlining key proposals for voting, including the election of directors and ratification of the company's accounting firm.
NASDAQ
PCVX
Vaxcyte, INC
DEF 14A: Vaxcyte's 2024 Proxy Statement: Stockholder Meeting to Address Director Elections, Auditor Ratification, and Executive Compensation
Vaxcyte's upcoming Annual Meeting of Stockholders on June 6, 2024, will address the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.